Patents Assigned to Travanti Pharma Inc.
-
Publication number: 20120022431Abstract: The present invention relates generally to iontophoretic drug delivery systems for transdermal delivery of therapeutic agents and, more particularly, to packaging such systems for long shelf life and easy assembly for use. The system package includes an iontophoretic skin worn patch component that accommodates a power source, electronics, electrodes and a drug pack component that carries a therapeutic agent which is contained as a separate sealed component. The packaged system further provides for ease of assembly at the time of use.Type: ApplicationFiled: September 3, 2009Publication date: January 26, 2012Applicant: Travanti Pharma Inc.Inventor: Todd A. Krinke
-
Publication number: 20110112465Abstract: A transdermal system for the delivery of an anesthetic or other active therapeutic agent directly to a selected site of injured skin tissue by iontophoresis is disclosed, which utilizes a transdermal skin-worn patch including a donor electrode chamber containing a donor electrode and an amount of an active agent in a form suitable for transdermal delivery in electrical communication with the donor electrode and a return electrode. The patch also contains a source of electric current connected in a circuit with the donor and return electrode, a current regulating device is optionally provided in the circuit for controlling the electrical output of the patch and at least the donor electrode chamber includes a provision for absorbing a quantity of fluid associated with weepage from adjacent injured skin tissue.Type: ApplicationFiled: January 20, 2011Publication date: May 12, 2011Applicant: Travanti Pharma Inc.Inventors: Carter R. Anderson, Russell L. Morris, Robert Cohen
-
Publication number: 20110092926Abstract: The potential for substance abuse involving residual amounts of abusable substances remaining in used skin-worn patches is reduced by the provision of a system and method for combining the abusable substance with a separate anti-abuse substance agent as part of a removal or disposal procedure.Type: ApplicationFiled: December 22, 2010Publication date: April 21, 2011Applicant: Travanti Pharma Inc.Inventors: Carter R. Anderson, Russell L. Morris
-
Transdermal Systems for the Delivery of Therapeutic Agents Including Granisetron Using Iontophoresis
Publication number: 20110087154Abstract: A disposable skin-worn device for the transdermal delivery at least one dose of charged therapeutic substances, including granisetron, by iontophoresis, the device comprising a donor reservoir containing an amount of a therapeutic substance to be delivered transdermally by iontophoresis, a counter reservoir, a source of electric power connected in a circuit between the donor reservoir and the counter reservoir and a control system for controlling current flow in the circuit to enable at least one dose of the therapeutic substance to be delivered transdermally by iontophoresis and wherein the control system includes a control element selected from the group consisting of a sensor activated by an external signal and a switch.Type: ApplicationFiled: November 29, 2010Publication date: April 14, 2011Applicant: Travanti Pharma Inc.Inventors: Carter R. Anderson, Walter L. Sembrowich, Russell L. Morris, Robert Cohen -
Publication number: 20110066130Abstract: The potential for substance abuse involving residual amounts of abusable substances remaining in used skin-worn patches is reduced by the provision of a system and method for combining the abusable substance with a separate anti-abuse substance agent as part of a removal or disposal procedure.Type: ApplicationFiled: November 23, 2010Publication date: March 17, 2011Applicant: Travanti Pharma Inc.Inventors: Carter R. Anderson, Russell L. Morris
-
Patent number: 7904146Abstract: A transdermal system for the delivery of an anesthetic or other active therapeutic agent directly to a selected site of injured skin tissue by iontophoresis is disclosed, which utilizes a transdermal skin-worn patch including a donor electrode chamber containing a donor electrode and an amount of an active agent in a form suitable for transdermal delivery in electrical communication with the donor electrode and a return electrode. The patch also contains a source of electric current connected in a circuit with the donor and return electrode, a current regulating device is optionally provided in the circuit for controlling the electrical output of the patch and at least the donor electrode chamber includes a provision for absorbing a quantity of fluid associated with weepage from adjacent injured skin tissue.Type: GrantFiled: November 9, 2007Date of Patent: March 8, 2011Assignee: Travanti Pharma Inc.Inventors: Carter R. Anderson, Russell L. Morris, Robert Cohen
-
Patent number: 7867511Abstract: The potential for substance abuse involving residual amounts of abusable substances remaining in used skin-worn patches is reduced by the provision of a system and method for combining the abusable substance with a separate anti-abuse substance agent as part of a removal or disposal procedure.Type: GrantFiled: January 23, 2004Date of Patent: January 11, 2011Assignee: Travanti Pharma Inc.Inventors: Carter R. Anderson, Russell L. Morris
-
Publication number: 20100324470Abstract: An electrode assembly for use in an iontophoresis device for the transcutaneous administration of an active therapeutic species has a base layer of including a linking conductive base material which is consumed (oxidizes or reduces) preferentially to water, a first upper layer of sacrificial material coated on a first portion of the base layer wherein the sacrificial material is consumed preferentially to the linking conductive base material of the base layer. A second upper layer of non-conducting material is coated on a second portion of the base layer, the second upper layer being spaced from the first upper layer, connected by a narrow exposed linking area of the base layer material remaining exposed therebetween.Type: ApplicationFiled: August 25, 2010Publication date: December 23, 2010Applicant: Travanti Pharma Inc.Inventors: Carter R. Anderson, Russell L. Morris
-
Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
Patent number: 7856263Abstract: A disposable skin-worn device for the transdermal delivery at least one dose of charged therapeutic substances, including granisetron, by iontophoresis, the device comprising a donor reservoir containing an amount of a therapeutic substance to be delivered transdermally by iontophoresis, a counter reservoir, a source of electric power connected in a circuit between the donor reservoir and the counter reservoir and a control system for controlling current flow in the circuit to enable at least one dose of the therapeutic substance to be delivered transdermally by iontophoresis and wherein the control system includes a control element selected from the group consisting of a sensor activated by an external signal and a switch.Type: GrantFiled: April 22, 2005Date of Patent: December 21, 2010Assignee: Travanti Pharma Inc.Inventors: Carter R. Anderson, Walter L. Sembrowich, Russell L. Morris, Robert Cohen -
Patent number: 7844327Abstract: An electrode assembly for use in an iontophoresis device for the transcutaneous administration of an active therapeutic species has a base layer of including a linking conductive base material which is consumed (oxidizes or reduces) preferentially to water, a first upper layer of sacrificial material coated on a first portion of the base layer wherein the sacrificial material is consumed preferentially to the linking conductive base material of the base layer. A second upper layer of non-conducting material is coated on a second portion of the base layer, the second upper layer being spaced from the first upper layer, connected by a narrow exposed linking area of the base layer material remaining exposed therebetween.Type: GrantFiled: October 2, 2003Date of Patent: November 30, 2010Assignee: Travanti Pharma Inc.Inventors: Carter R. Anderson, Russell L. Morris
-
Publication number: 20100068250Abstract: The potential for substance abuse involving residual amounts of abusable substances remaining in used skin-worn patches is reduced by the provision of a system and method for combining the abusable substance with a separate anti-abuse substance agent as part of a removal or disposal procedure.Type: ApplicationFiled: November 19, 2009Publication date: March 18, 2010Applicant: Travanti Pharma Inc.Inventors: Carter R. Anderson, Russell L. Morris
-
Publication number: 20090180936Abstract: The potential for environmental release of unused and expired medications is reduced by the provision of a system and method for combining the unused or expired medication with an amount of activated carbon as part of a disposal procedure.Type: ApplicationFiled: March 26, 2009Publication date: July 16, 2009Applicant: TRAVANTI PHARMA, INC.Inventors: Carter R. Anderson, Russell L. Morris
-
Publication number: 20090062720Abstract: An integrated iontophoresis skin-worn patch and method for delivering a therapeutically effective amount of a corticosteroid drug compound in a systemically-safe and skin-safe manner for site-specific treatment of inflammation pain is disclosed.Type: ApplicationFiled: August 27, 2008Publication date: March 5, 2009Applicant: TRAVANTI PHARMA INC.Inventors: Carter R. Anderson, Russell L. Morris, Robert Cohen, William V. Fowler
-
Publication number: 20080114284Abstract: A transdermal system for the delivery of an anesthetic or other active therapeutic agent directly to a selected site of injured skin tissue by iontophoresis is disclosed, which utilizes a transdermal skin-worn patch including a donor electrode chamber containing a donor electrode and an amount of an active agent in a form suitable for transdermal delivery in electrical communication with the donor electrode and a return electrode. The patch also contains a source of electric current connected in a circuit with the donor and return electrode, a current regulating device is optionally provided in the circuit for controlling the electrical output of the patch and at least the donor electrode chamber includes a provision for absorbing a quantity of fluid associated with weepage from adjacent injured skin tissue.Type: ApplicationFiled: November 9, 2007Publication date: May 15, 2008Applicant: TRAVANTI PHARMA INC.Inventors: Carter R. Anderson, Russell L. Morris, Robert Cohen
-
Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
Publication number: 20060253061Abstract: A disposable skin-worn device for the transdermal delivery at least one dose of charged therapeutic substances, including granisetron, by iontophoresis, the device comprising a donor reservoir containing an amount of a therapeutic substance to be delivered transdermally by iontophoresis, a counter reservoir, a source of electric power connected in a circuit between the donor reservoir and the counter reservoir and a control system for controlling current flow in the circuit to enable at least one dose of the therapeutic substance to be delivered transdermally by iontophoresis and wherein the control system includes a control element selected from the group consisting of a sensor activated by an external signal and a switch.Type: ApplicationFiled: April 22, 2005Publication date: November 9, 2006Applicant: Travanti Pharma Inc.Inventors: Carter Anderson, Walter Sembrowich, Russell Morris, Robert Cohen